Normal Amphetamine Quantitative Levels
For urine amphetamine testing, concentrations ≥500 ng/mL (with amphetamine ≥200 ng/mL) are considered positive for confirmation purposes, while plasma peak concentrations after therapeutic dosing typically range from 23.5-36.6 ng/mL.
Urine Concentrations
The standard confirmation cutoffs for workplace and clinical drug testing are:
- Methamphetamine: ≥500 ng/mL (or ≥250 ng/mL with proposed lower cutoffs)
- Amphetamine: ≥200 ng/mL (or ≥100 ng/mL with proposed lower cutoffs) 1
After therapeutic dosing with Adderall (20 mg), peak urine amphetamine concentrations ranged from 2,645 to 5,948 ng/mL, with concentrations ≥500 ng/mL detectable for up to 47.5 hours post-dose 2. Following a single 10 mg dexamphetamine dose, amphetamine was first detected at 82-1,827 ng/mL in initial voids (0.7-11.3 hours post-administration) 3.
The urine-to-blood concentration ratio averages approximately 200:1 (mean 214, median 160), though individual variation is substantial 4. This ratio is significantly influenced by:
- Urinary pH: Lower pH increases amphetamine excretion (negative correlation, P<0.005)
- Urine creatinine: Normalizing for creatinine improves correlation between blood and urine levels 4
Critical Specimen Validity Parameters
Urine creatinine concentration between 2-20 mg/mL indicates a dilute specimen 5. Specimens with creatinine ≤2 mg/mL should be considered substituted and treated as positive, warranting referral to addiction specialists 5.
Plasma Concentrations
Following therapeutic dosing:
- 15 mg sustained-release dexamphetamine: Peak plasma concentration (Cmax) of 23.5 ng/mL at approximately 8 hours
- Three 5 mg immediate-release tablets: Cmax of 36.6 ng/mL at approximately 3 hours
- Plasma half-life: Approximately 12 hours for both formulations 6
After 70 mg lisdexamfetamine (prodrug), d-amphetamine reached maximum plasma concentration at 3.8 hours post-administration 7.
Detection Windows
Amphetamine remains detectable in urine for 67-78 hours after single therapeutic doses of dexamphetamine (10 mg) or lisdexamfetamine (30 mg), using a 1.5 ng/mL cutoff in oral fluid and 50 ng/mL in urine 3. Detection windows are comparable between urine and oral fluid when appropriate cutoffs are used.
Clinical Interpretation Pitfalls
Lowering cutoffs from 500/200 ng/mL to 250/100 ng/mL extends detection windows by up to 24-34 hours and increases positive specimen rates by 48% 1. This has significant implications for distinguishing recent therapeutic use from abuse.
Individual variability in detection times is substantial due to:
- pH-dependent renal excretion
- Fluid intake and urine dilution
- Individual metabolic differences
- Timing of urine voids relative to dosing 3, 4
Enantiomer analysis can differentiate Adderall (3:1 d:l ratio) from pure dexamphetamine formulations or illicit amphetamine, as the proportion of l-enantiomer increases over time due to differential metabolism 2.